资讯

Learn more about how the liver processes bilirubin and what happens if an infant has excess bilirubin, which is common in ...
Researchers design a nanovaccine that detects MRSA toxins, kills bacteria with heat, and captures antigens to train the ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...
Vietnam Investment Review on MSN8 小时
Jenscare shares key valve study results at EuroPCR 2025
Breakthroughs in tricuspid and mitral valve repair signal progress in heart treatment. BEIJING, June 3, 2025 /PRNewswire/ -- ...
This increase in electrostatic charge is desirable for achieving hemocompatibility, as evidenced by a range of blood compatibility assessments, including hemolysis, blood clotting, platelet adhesion, ...
U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000 <li /> A full 45 ...
"A good waveform and a good catheter design is worth nothing if the physician doesn't know where this catheter is located ...
A Yorba Linda woman who wanted nothing more than to be a mom was able to spend nine days with her newborn twins when a little ...
Being allowed to return home was a doubled-edged sword: as the Covid pandemic was still raging, the family began to feel ...
The toxic effects determined based on the hemolysis, membrane injury, lipid peroxidation, and antioxidant enzyme production were fairly size and dose dependent. In particular, the smallest sized ...
Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day follow-up results of TRINITY Trial of LuX-Valve Plus, a ...